ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,002Medicare Part D Prescriptions Filled, Including Refills

Rank: 1595 out of 5254

$742K Total Retail Price of All Prescriptions

Rank: 705 out of 5254

251 Patients Receiving at Least One Drug in Part D
82% Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New York
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 251 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%. This is far more than peers.

Prescription Price

$106 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 293 262 48 1 16
LOVAZA 282 226 44 2 43
AMLODIPINE BESYLATE 225 212 43 3 2
NEXIUM 194 163 36 4 18
CARVEDILOL 141 129 20 5 25
METOPROLOL SUCCINATE 141 136* 31 5 10
GABAPENTIN 136 122 23 7 20
BENICAR HCT 127 122* 19 8 100
CLOPIDOGREL 125 120* 18 9 15
LIDODERM 123 118* 38 10 64
TAMSULOSIN HCL 123 123 18 10 19
FUROSEMIDE 116 98 30 12 8
LOSARTAN-HYDROCHLOROTHIAZIDE 105 100* 20 13 29
ATORVASTATIN CALCIUM 105 90 29 13 3
VOLTAREN 104 90 41 15 65
SYMBICORT 99 83 25 16 113
ADVAIR DISKUS 94 72 16 17 32
LOSARTAN POTASSIUM 92 87* 18 18 12
CALCITONIN-SALMON 92 87* 18 18 293
JANUMET 88 74 15 20 74
VALSARTAN-HYDROCHLOROTHIAZIDE 87 82* 14 21 49
METOPROLOL TARTRATE 85 58 19 22 9
SIMVASTATIN 77 72* 16 23 1
ATENOLOL 76 62 20 24 14
SYNTHROID 76 76 12 24 30
DIOVAN 73 68* 12 26 23
RAMIPRIL 72 <11 <11 27 50
RANITIDINE HCL 72 67* 14 27 41
LEVOTHYROXINE SODIUM 70 70 11 29 4
DONEPEZIL HCL 68 68 13 30 28
SERTRALINE HCL 68 63* 12 30 27
CHLORHEXIDINE GLUCONATE 67 62* 12 32 197
METFORMIN HCL 64 48 13 33 7
ENALAPRIL MALEATE 63 52 14 34 24
NAMENDA 61 56* 12 35 38
OMEPRAZOLE 57 36 15 36 5
CELEBREX 57 52* 13 36 76
BENICAR 55 <11 <11 38 94
OLANZAPINE 54 <11 <11 A 39 123
DEXILANT 51 <11 <11 40 102
MONTELUKAST SODIUM 50 <11 <11 41 35
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.